GeneDx Holdings Corp. (WGSWW)

Market Cap	3.02B
Revenue (ttm)	362.32M
Net Income (ttm)	1.41M
Shares Out	28.73M
EPS (ttm)	0.05
PE Ratio	2,147.93
Forward PE	46.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,874
Open	0.0975
Previous Close	0.0987
Day's Range	0.0830 - 0.0987
52-Week Range	0.0220 - 0.3410
Beta	2.08
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 18, 2025

About WGSWW

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2017
• Employees: 1,000
• Stock Exchange: NASDAQ
• Ticker Symbol: WGSWW
• Website: https://www.genedx.com